About Borje Andersson
Form D filings for GreenJay Therapeutics from 2023 to 2024 list Borje Andersson as director.
Borje Andersson first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Borje Andersson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Borje Andersson works with at each company, as listed on that company's latest Form D.
GreenJay Therapeutics, Inc. · Form D, Apr 22, 2024